Covered recipient · General Payments record
CHERI A WEISNER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2025
$3,795.81
- Reported across 88 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,286.11 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $496.66 | 4 |
| Novo Nordisk AS | $480.71 | 4 |
| Amgen Inc. | $149.95 | 2 |
| Lilly USA, LLC | $83.83 | 1 |
| GlaxoSmithKline, LLC. | $74.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $29.99 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228799021 | CMS |
| Amgen Inc. | $119.96 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228799027 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.66 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206228767 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.74 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206242700 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.65 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206156428 | CMS |
| AstraZeneca Pharmaceuticals LP | $128.61 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206980532 | CMS |
| GlaxoSmithKline, LLC. | $74.96 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190638445 | CMS |
| Lilly USA, LLC | $83.83 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187012822 | CMS |
| Novo Nordisk Inc | $122.98 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188665685 | CMS |
| Novo Nordisk Inc | $124.99 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188334325 | CMS |
| Novo Nordisk Inc | $107.74 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188873472 | CMS |
| Novo Nordisk Inc | $125.00 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188842340 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.